- Home
- BRLT vs CALC Comparison
BRLT vs CALC Comparison
Compare BRLT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- CALC
- Stock Information
- Founded
- BRLT 2005
- CALC 2011
- Country
- BRLT United States
- CALC United States
- Employees
- BRLT N/A
- CALC N/A
- Industry
- BRLT Consumer Specialties
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- CALC Health Care
- Exchange
- BRLT Nasdaq
- CALC Nasdaq
- Market Cap
- BRLT 21.8M
- CALC 22.9M
- IPO Year
- BRLT 2021
- CALC N/A
- Fundamental
- Price
- BRLT $1.38
- CALC $1.60
- Analyst Decision
- BRLT Hold
- CALC Strong Buy
- Analyst Count
- BRLT 3
- CALC 3
- Target Price
- BRLT $1.80
- CALC $16.33
- AVG Volume (30 Days)
- BRLT 54.4K
- CALC 28.4K
- Earning Date
- BRLT 08-07-2025
- CALC 08-11-2025
- Dividend Yield
- BRLT N/A
- CALC N/A
- EPS Growth
- BRLT N/A
- CALC N/A
- EPS
- BRLT N/A
- CALC N/A
- Revenue
- BRLT $418,708,000.00
- CALC N/A
- Revenue This Year
- BRLT $3.79
- CALC N/A
- Revenue Next Year
- BRLT $3.85
- CALC N/A
- P/E Ratio
- BRLT N/A
- CALC N/A
- Revenue Growth
- BRLT N/A
- CALC N/A
- 52 Week Low
- BRLT $1.25
- CALC $1.42
- 52 Week High
- BRLT $2.68
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- BRLT 49.19
- CALC 32.78
- Support Level
- BRLT $1.32
- CALC $1.48
- Resistance Level
- BRLT $1.40
- CALC $1.79
- Average True Range (ATR)
- BRLT 0.05
- CALC 0.12
- MACD
- BRLT 0.00
- CALC -0.02
- Stochastic Oscillator
- BRLT 50.00
- CALC 0.00
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.